Get started
GBLX CURE ETF UNITSGBLX CURE ETF UNITSGBLX CURE ETF UNITS

GBLX CURE ETF UNITS

No trades
See on Supercharts
Overview
Analysis News Discussions Technicals Seasonals

CURE chart


Full chart

Key stats


Assets under management (AUM)
‪34.13 M‬ AUD
Fund flows (1Y)
‪−8.02 M‬ AUD
Dividend yield (indicated)
—
Discount/Premium to NAV
1.2%
Shares outstanding
‪704.01 K‬
Expense ratio
0.45%

About GBLX CURE ETF UNITS


Issuer
Mirae Asset Global Investments Co., Ltd.
Brand
Global X
Home page
etfsecurities.com.au
Inception date
Nov 8, 2018
Index tracked
S&P Biotechnology Select Industry
Replication method
Physical
Management style
Passive
Distributes
Capital Gains
ISIN
AU0000028110
The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Equal
Geography
U.S.
Weighting scheme
Equal
Selection criteria
Market cap

CURE analysis


What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Stock breakdown by region
100%

CURE news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.